Skip to main content

Interactions of Fungal and Plant Toxins with DNA: Aflatoxins, Sterigmatocystin, Safrole, Cycasin, and Pyrrolizidine Alkaloids

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 94 / 1))

Abstract

Since the discovery of the aflatoxins in 1960, much effort has been made by research laboratories to investigate the association between exposure to naturally occurring carcinogens and long-term adverse health effects in people. In the case of aflatoxin B1, these health consequences range from acute hepatic liver toxicities to liver cancer. During the ensuing years, the vast majority of the mechanistic biochemical studies inquiring into the mode of action of naturally occurring chemical carcinogens have been carried out using aflatoxin Bl. In fact, the aflatoxins are among the few ubiquitous and structurally identified environmental carcinogens for which quantitative estimates of human exposure have been systematically sought and risk assessments attempted. However, in the past 10 years compounds such as sterigmatocystin, cycasin, the family of pyrrolizidine alkaloids, and especially safrole and estragole have been more extensively probed. Stimulus for this research has undoubtedly been generated by the hypothesis that prevention of dietary exposure to naturally occurring plant and fungal carcinogens will improve the general health status of a population. Since it is almost axiomatic that the development of human cancer can be modulated by many factors both biological and chemical in nature, and because initiation, promotion, and progression-like events are required prior to the clinical diagnosis of a tumor, no one agent can be responsible for, or present at all the critical stages during the growth of a tumor. Therefore, the systematic investigation of the biological consequences of exposure to dietary carcinogens will help to develop appropriate cancer prevention strategies.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Autrup H, Bradley KA, Shamsuddin AKM, Wakhisi J, Wasunna A (1983) Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7’-guanyl)- 3-hydroxyaflatoxin B1 in human urine collected in Murang’a district, Kenya. Carcinogenesis 4 (9): 1193–1195

    Article  PubMed  CAS  Google Scholar 

  • Autrup H, Seremet T, Wakhisi J, Wasunna A (1987) Aflatoxin exposure measured by urinary excretion of aflatoxin Bt-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res 47: 3430–3433

    PubMed  CAS  Google Scholar 

  • Bennett RA, Essigmann JM, Wogan GN (1981) Excretion of an aflatoxin-guanine adduct in urine of aflatoxin B1-treated rats. Cancer Res 41: 650–654

    PubMed  CAS  Google Scholar 

  • Bishop JM (1985) Viral oncogenes. Cell 42: 23–38

    Article  PubMed  CAS  Google Scholar 

  • Bulatao-Jayme J, Almero EM, Castro CA, Jardeleza TR, Salamat L (1982) A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11: 112–119

    Article  PubMed  CAS  Google Scholar 

  • Busby WF, Wogan GN (1984) Aflatoxins. In: Searle CE (ed) Chemical carcinogens, 2nd edn. American Chemical Society, Washington DC, pp 945–1136

    Google Scholar 

  • Cabral JRP, Neal GE (1983) The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett 9: 125–132

    Article  Google Scholar 

  • Campbell AA, Whitaker TB, Pohland AE, Dickens JW, Park DL (1986) Sampling, sample preparation, and sampling plans for foodstuffs for mycotoxion analysis. Pure and Applied Chemistry 58: 305–314

    Article  CAS  Google Scholar 

  • Campbell TC, Caedo JP, Bulatao-Jayme J, Salamat L, Engel RW (1970) Aflatoxin M1 in human urine. Nature 227: 403–404

    Article  PubMed  CAS  Google Scholar 

  • Candrian U, Luthy J, Schlatter C (1985) In vivo covalent binding of retronecine-labelled [3H] senecionine to DNA of rat liver, lung and kidney. Chem Biol Interact 54: 57–69

    Article  PubMed  CAS  Google Scholar 

  • Croy RG, Wogan GN (1981) Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res 41: 197–203

    PubMed  CAS  Google Scholar 

  • Croy RG, Essigmann JM, Reinhold VN, Wogan GN (1978) Identification of the principle aflatoxin Bl-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci USA 75: 1745–1749

    Article  PubMed  CAS  Google Scholar 

  • Cullen JM, Ruebner BH, Hseih LS, Hyde DM, Hseih DP (1987) Carcinogenicity of dietary aflatoxin Ml in male Fischer rats compared to aflatoxin Bl. Cancer Res 47: 1913–1917

    PubMed  CAS  Google Scholar 

  • DeLong MJ, Prochaska HJ, Talalay P (1983) Substituted phenols as inducers of enzymes which inactivate electrophilic compounds. In: McBrien DC, Slater TF (eds) Protective agents in human and experimental cancer. Academic, London, pp 175–196

    Google Scholar 

  • Donahue PR, Essigmann JM, Wogan GN (1982) Alfatoxin-DNA adducts: detection in urine as a dosimeter of exposure. Banbury Report 13: 221–229

    CAS  Google Scholar 

  • Essigmann JM, Croy RG, Nadzan AM, Busby WF Jr, Reinhold VN, Buchi G, Wogan GN (1977) Structural identification of the major DNA adduct formed by aflatoxin Bl in vitro. Proc Natl Acad Sci USA 74: 1870–1874

    Article  PubMed  CAS  Google Scholar 

  • Essigmann JM, Barker LJ, Fowler KW, Francisco MA, Reinhold VN, Wogan GN (1979) Sterigmatocystin-DNA interactions: identification of a major adduct formed after metabolic activation in vitro. Proc Natl Acad Sci USA 76: 179–183

    Article  PubMed  CAS  Google Scholar 

  • Fennell TR, Wiseman RW, Miller JA, Miller EC (1985) Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1’-hydroxy-2’,3’-dehydroestragole in infant male C57BL/6J × C3H/HeJ F1 mice. Cancer Res 45: 5310–5320

    PubMed  CAS  Google Scholar 

  • Fennell TR, Juhl U, Miller EC, Miller J A (1986) Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from l’-hydroxy-2’,3’-dehydroestragole: comparison of the adducts detected with the r-3H-labelled carcinogen and by 32P- postlabelling. Carcinogenesis 7: 1881–1887

    Article  PubMed  CAS  Google Scholar 

  • Goeger DE, Shelton DW, Hendricks JD, Bailey GS (1986) Mechanisms of anti- carcinogenesis by indole-3-carbinol: effect on the distribution and metabolism of aflatoxin Bl in rainbow trout. Carcinogenesis 7: 2025–2031

    Article  PubMed  CAS  Google Scholar 

  • Groopman JD, Kensler TW (1987) The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin Bl. Pharmacol Ther 34: 321–334

    Article  PubMed  CAS  Google Scholar 

  • Groopman JD, Busby WF Jr, Wogan GN (1980) Nuclear distribution of aflatoxin Bl and its interaction with histones in rat liver in vivo. Cancer Res 40: 4343–4351

    PubMed  CAS  Google Scholar 

  • Groopman JD, Haugen A, Goodrich GR, Harris CC (1982) Quantitation of aflatoxin Bl modified DNA using monoclonal antibodies. Cancer Res 42: 3120–3124

    PubMed  CAS  Google Scholar 

  • roopman JD, Trudel LJ, Donahue PR, Rothstein A, Wogan GN (1984) High affinity monoclonal antibodies for aflatoxins and their application to solid phase immunoassay. Proc Natl Acad Sci USA 81: 7728–7731

    Article  Google Scholar 

  • Groopman JD, Donahue PR, Zhu J, Chen J, Wogan GN (1985) Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci USA 82: 6492–6497

    Article  PubMed  CAS  Google Scholar 

  • Groopman JD, Busby WF, Donahue PR, Wogan GN (1986) Aflatoxins as risk factors for liver cancer: an application of monoclonal antibodies to monitor human exposure. In: Harris CC (ed) Biochemical and molecular epidemiology of cancer. Liss, New York, pp 233–256

    Google Scholar 

  • Groopman JD, Donahue PR, Zhu J, Chen J, Wogan GN (1987) Temporal patterns of aflatoxin metabolites in urine of people living in Guangxi Province, P.R.C. Proc Am Assoc Cancer Res 28: 36

    Google Scholar 

  • Gurtoo HL, Dahms RP, Paigen B (1975) Metabolic activation of aflatoxins related to their mutagenicity. Biochem Biophys Res Comm 61. 735–742

    Article  Google Scholar 

  • Gurtoo HL, Koser PL, Bansal SK, Fox HW, Sharma SD, Mulhern AI, Pavelic ZP (1985) Inhibition of aflatoxin Bl-hepatocarcinogenesis in rats by B-napthoflavone. Carcinogenesis 6: 675–678

    Article  PubMed  CAS  Google Scholar 

  • Haugen A, Groopman JD, Hsu IC, Goodrich GR, Wogan GN, Harris CC (1981) Monoclonal antibody to aflatoxin B1 modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci USA 78: 4124–4127

    Article  PubMed  CAS  Google Scholar 

  • Hertzog PJ, Lindsay Smith JR, Garner RC (1982) Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin Bl-DNA, the persistent DNA adduct in vivo. Carcinogenesis 3: 723–725

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann GR, Morgan RW (1984) Review: putative mutagens and carcinogens in foods. V. Cycad azoxyglycosides. Environ Mutagen 6: 103–116

    Google Scholar 

  • Jeffrey AM (1985) DNA modification by chemical carcinogens. Pharmacol Ther 28: 237–272

    Article  PubMed  CAS  Google Scholar 

  • Kensler TW, Enger PA, Trush MA, Bueding E, Groopman JD (1985) Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis 6: 759–763

    Article  PubMed  CAS  Google Scholar 

  • Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD (1986) Modulation of aflatoxin metabolism, aflatoxin N7-guanine formation and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res 46: 3924–3931

    PubMed  CAS  Google Scholar 

  • Lin JK, Miller JA, Miller EC (1977) 2,3-Dihydro-2(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin Bl-DNA or -ribosomal RNA adducts formed in hepatic microsome mediated reactions in rat liver in vivo. Cancer Res 37: 4430–4438

    Google Scholar 

  • Linsell CA, Peers FG (1977) Aflatoxin and liver cancer. Trans R Soc Trop Med Hyg 71: 471–473

    Article  PubMed  CAS  Google Scholar 

  • Mandel HG, Manson MM, Judah DJ, Simpson JL, Green JA, Forrester LM, Wolf CR, Neal GE (1987) Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin Bl hepatocarcinogenesis in the rat. Cancer Res 47: 5218–5223

    PubMed  CAS  Google Scholar 

  • McLean AEM, Marshall A (1971) Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br J Exp Pathol 52: 322–329

    CAS  Google Scholar 

  • McMahon G, Hanson L, Lee J J, Wogan GN (1986) Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc Natl Acad Sci USA 83: 9418–9422

    Article  PubMed  CAS  Google Scholar 

  • McMahon G, Davis E, Wogan GN (1987) Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci USA 84: 4974–4978

    Article  PubMed  CAS  Google Scholar 

  • Miller EC, Miller J A (1986) Carcinogens and mutagens that may occur in foods. Cancer 58: 1795–1803

    Article  PubMed  CAS  Google Scholar 

  • Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller J A (1983) Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res 43: 1124–1134

    PubMed  CAS  Google Scholar 

  • Miller J A, Miller EC (1983) The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragóle. Br J Cancer 48: 1–15

    Article  PubMed  CAS  Google Scholar 

  • Morgan RW, Hoffmann GR (1983) Cycasin and its mutagenic metabolites. Mutat Res 114: 19–58

    PubMed  CAS  Google Scholar 

  • National Cancer Office of the Ministry of Public Health, P.R.C. (1980) Studies on mortality rates of cancer in China. People’s Publishing House, Beijing

    Google Scholar 

  • Peers F, Bosch X, Kaldor J, Linsell A, Pluijmen M (1987) Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 39: 545–553

    Article  PubMed  CAS  Google Scholar 

  • Pestka JJ, Chu FS (1982) Reactivity of aflatoxin B2a antibody with aflatoxin Bl-modified DNA and related metabolites. Appl Environ Microbiol 44: 1159–1165

    PubMed  CAS  Google Scholar 

  • Petry TW, Bowden GT, Huxtable RJ, Sipes IG (1984) Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Cancer Res 44: 1505–1509

    PubMed  CAS  Google Scholar 

  • Phillips DH, Miller J A, Miller EC, Adams B (1981) N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1’-hydroxysafrole to mouse liver DNA in vivo. Cancer Res 41: 2664–2671

    PubMed  CAS  Google Scholar 

  • Phillips DH, Reddy MV, Randerath K (1984) 32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice. Carcinogenesis 5: 1623–1628

    Google Scholar 

  • Randerath K, Haglund RE, Phillips DH, Reddy MV (1984) 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenyl-benzenes. I. Adult female CD-1 mice. Carcinogenesis 5: 1613–1622

    Google Scholar 

  • Reddy MY, Irvin TR, Randerath K (1985) Formation and persistence of sterigmatocystin-DNA adducts in rat liver determined via 32P-postlabeling analysis. Mutat Res 152: 85–96

    Article  PubMed  CAS  Google Scholar 

  • Robertson KA (1982) Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline. Cancer Res 42: 8–14

    PubMed  CAS  Google Scholar 

  • Robins DJ (1982) The pyrrolizidine alkaloids. Fortschr Chem Org Naturst 41: 115–203

    PubMed  CAS  Google Scholar 

  • Sabbioni G, Skipper P, Buchi G, Tannenbaum SR (1987) Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 8: 819–824

    Article  PubMed  CAS  Google Scholar 

  • Schoental R (1982) Health hazards of pyrrolizidine alkaloids: a short review. Toxicol Lett 10: 323–326

    Article  PubMed  CAS  Google Scholar 

  • Shamsuddin AM, Harris CC, Hinzman MJ (1987) Localization of aflatoxin B1-nucleic acid adducts in mitochondria and nuclei. Carcinogenesis 8: 109–114

    Article  PubMed  CAS  Google Scholar 

  • Shank RC, Magee PN (1967) Similarities between the biochemical actions of cycasin and dimethyluitrosamine. Biochem J 105: 521–527

    PubMed  CAS  Google Scholar 

  • Stoloff L (1980) Aflatoxin control — past and present. J Assoc Off Anal Chem 63: 1067–1073

    PubMed  CAS  Google Scholar 

  • Sun TT, Chu YY (1984) Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J Cell Physiol [Suppl i] 3: 39–44

    Article  CAS  Google Scholar 

  • Sun TT, Chu YR, Hsia CC, Wei YP, Wu SM (1986) Strategies and current trends of etiologic prevention of liver cancer. In: Harris CC (ed) Biochemical and molecular epidemiology. Liss, New York, pp 283–292

    Google Scholar 

  • Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF (1985) Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51: 713–726

    Article  PubMed  Google Scholar 

  • Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230: 770–776

    Article  PubMed  CAS  Google Scholar 

  • Wild CP, Umbenhauer D, Chapot B, Montesano R (1986) Monitoring of individual human exposure to aflatoxins (AF) and N~nitrosamines ( NNO) by immunoassays. J Cell Biochem 30: 171–179

    Google Scholar 

  • Wild CP, Garner RG, Montesano R, Tursi F (1986) Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 7: 853–858

    Article  PubMed  CAS  Google Scholar 

  • Williams GM, Tanaka T, Maeura Y (1986) Dose-dependent inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxytoluene and butylated hydroxyanisole. Carcinogenesis 7: 1043–1050

    Article  PubMed  CAS  Google Scholar 

  • Wiseman RW, Fennell TR, Miller JA, Miller EC (1985) Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1’-hydroxysafrole and l’-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues. Cancer Res 45: 3096–3105

    PubMed  CAS  Google Scholar 

  • Wiseman RW, Stowers SJ, Miller EC, Anderson MW, Miller J A (1986) Activating mutations of the c-Ha-ras1 protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc Natl Acad Sci USA 83: 5825–5829

    Article  PubMed  CAS  Google Scholar 

  • Wiseman RW, Miller EC, Miller JA, Liem A (1987) Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J × C3H/HeJ F1 mice. Cancer Res 47: 2275–2283

    PubMed  CAS  Google Scholar 

  • Wogan GN (1976) The induction of liver cancer by chemicals. In: Linsell DA, Warwick GP (eds) Liver cell cancer. Elsevier, New York, pp 121–150

    Google Scholar 

  • Wong JJ, Hsieh DPH (1976) Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential. Proc Natl Acad Sci USA 73: 2241–2244

    Article  PubMed  CAS  Google Scholar 

  • Yeh FS, Mo CC, Yen RC (1985) Risk factors for hepatocellular carcinoma in Guangxi, People’s Republic of China. Nat Cancer Inst Monogr 69: 47–48

    Google Scholar 

  • Zedeck MS (1984) Hydrazine derivatives, azo and azoxy compounds, and methylazoxymethanol and cycasin. In: Searle CE (ed) Chemical carcinogens, 2nd edn. American Chemical Society, New York, pp 915–944

    Google Scholar 

  • Zhu JQ, Zhang LS, Hu X, Xiao Y, Chen JS, Xu YC, Fremy J, Chu FS (1987) Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Cancer Res 47: 1848–1852

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Groopman, J.D., Cain, L.G. (1990). Interactions of Fungal and Plant Toxins with DNA: Aflatoxins, Sterigmatocystin, Safrole, Cycasin, and Pyrrolizidine Alkaloids. In: Cooper, C.S., Grover, P.L. (eds) Chemical Carcinogenesis and Mutagenesis I. Handbook of Experimental Pharmacology, vol 94 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74775-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74775-5_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74777-9

  • Online ISBN: 978-3-642-74775-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics